CN104040339A - 吸收性纸及其用于乳腺癌检测的用途 - Google Patents

吸收性纸及其用于乳腺癌检测的用途 Download PDF

Info

Publication number
CN104040339A
CN104040339A CN201280064266.1A CN201280064266A CN104040339A CN 104040339 A CN104040339 A CN 104040339A CN 201280064266 A CN201280064266 A CN 201280064266A CN 104040339 A CN104040339 A CN 104040339A
Authority
CN
China
Prior art keywords
absorbent paper
sample
teat
paper
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280064266.1A
Other languages
English (en)
Chinese (zh)
Inventor
史蒂文·C·夸伊
书志·陈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atropic SA Genetics Corp
Original Assignee
Atropic SA Genetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atropic SA Genetics Corp filed Critical Atropic SA Genetics Corp
Publication of CN104040339A publication Critical patent/CN104040339A/zh
Pending legal-status Critical Current

Links

Classifications

    • G01N33/57515—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0041—Detection of breast cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G01N33/683—Total protein determination, e.g. albumin in urine involving metal ions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G01N33/683—Total protein determination, e.g. albumin in urine involving metal ions
    • G01N33/6836—Silver staining

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201280064266.1A 2011-10-24 2012-10-24 吸收性纸及其用于乳腺癌检测的用途 Pending CN104040339A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161550855P 2011-10-24 2011-10-24
US61/550,855 2011-10-24
PCT/US2012/061733 WO2013063147A1 (en) 2011-10-24 2012-10-24 Absorbent paper and use thereof for breast cancer detection

Publications (1)

Publication Number Publication Date
CN104040339A true CN104040339A (zh) 2014-09-10

Family

ID=48168446

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280064266.1A Pending CN104040339A (zh) 2011-10-24 2012-10-24 吸收性纸及其用于乳腺癌检测的用途

Country Status (6)

Country Link
US (3) US9052318B2 (enExample)
EP (1) EP2771686A4 (enExample)
JP (1) JP2015505359A (enExample)
CN (1) CN104040339A (enExample)
CA (1) CA2853343A1 (enExample)
WO (1) WO2013063147A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013063147A1 (en) * 2011-10-24 2013-05-02 Atossa Genetics, Inc. Absorbent paper and use thereof for breast cancer detection
CN107076747B (zh) * 2014-06-04 2021-02-02 阿托萨治疗学公司 分子乳房摄影术
JP6518260B2 (ja) * 2014-09-02 2019-05-22 ダービン・シエ ポリメラーゼ連鎖反応の方法及び装置

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030211624A1 (en) * 2001-11-20 2003-11-13 Board Of Regents, The University Of Texas System Proteomic methods for diagnosis and monitoring of breast cancer
US20060030787A1 (en) * 1996-08-27 2006-02-09 Quay Steven C Devices and methods for obtaining mammary fluid samples for evaluating breast diseases, including cancer
CN101223445A (zh) * 2005-05-26 2008-07-16 约翰·霍普金斯大学 乳腺癌的生物标志
WO2009059393A1 (en) * 2007-11-06 2009-05-14 University Health Network Method for the detection of breast cancer by determining alcam and/or bcam levels in a patient sample

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3786801A (en) * 1969-02-24 1974-01-22 Diagnostic Inc Method and apparatus for aiding in the detection of breast cancer
GB8415998D0 (en) 1984-06-22 1984-07-25 Janssen Pharmaceutica Nv Staining method
JPS6294170A (ja) * 1985-10-21 1987-04-30 ピジヨン株式会社 搾乳器
US5340746A (en) * 1993-01-08 1994-08-23 Minnesota Mining And Manufacturing Company Composite reactive articles for the determination of cyanide
JPH09149890A (ja) * 1995-09-27 1997-06-10 Hisamitsu Pharmaceut Co Inc 検査用貼付剤およびその検出装置並びに検査方法
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
CA2350502C (en) * 1998-11-13 2009-01-27 Pro Duct Health, Inc. Devices and methods to identify ductal orifices during nipple aspiration
WO2001085023A2 (en) * 2000-05-10 2001-11-15 Cytyc Health Corporation Method for differentiating breast ducts for cancer risk status
US20020013539A1 (en) * 2000-07-28 2002-01-31 David Hung Methods and devices for diagnosis of precancer and cancer in breast milk ducts
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
US7128887B2 (en) 2003-05-29 2006-10-31 Specialty Minerals (Michigan) Inc. Platy precipitated calcium carbonate synthesis method
JP2008515871A (ja) 2004-10-07 2008-05-15 ナショナル インスティテュート オブ イミュノロジー 新規ガン関連抗体及び抗原並びにガンの診断におけるそれらの使用
WO2006062802A2 (en) * 2004-12-08 2006-06-15 Wang Paul C Device for non-surgical correction of congenital inverted nipples and/or collection of nipple aspirate fluid
US20100256464A1 (en) 2007-05-14 2010-10-07 Dr. Susan Love Research Foundation Device for determining risk of developing breast cancer and method thereof
US20130115629A1 (en) 2011-10-24 2013-05-09 Atossa Genetics, Inc. Methods of breast cancer detection
WO2013063147A1 (en) 2011-10-24 2013-05-02 Atossa Genetics, Inc. Absorbent paper and use thereof for breast cancer detection

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060030787A1 (en) * 1996-08-27 2006-02-09 Quay Steven C Devices and methods for obtaining mammary fluid samples for evaluating breast diseases, including cancer
US20030211624A1 (en) * 2001-11-20 2003-11-13 Board Of Regents, The University Of Texas System Proteomic methods for diagnosis and monitoring of breast cancer
CN101223445A (zh) * 2005-05-26 2008-07-16 约翰·霍普金斯大学 乳腺癌的生物标志
WO2009059393A1 (en) * 2007-11-06 2009-05-14 University Health Network Method for the detection of breast cancer by determining alcam and/or bcam levels in a patient sample

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SAVITRI KRISHNAMURTHY ET AL.: "Nipple Aspirate Fluid Cytology in Breast Carcinoma", 《CANCER》, vol. 99, no. 2, 25 April 2003 (2003-04-25), pages 97 - 104, XP055166343, DOI: doi:10.1002/cncr.10958 *

Also Published As

Publication number Publication date
JP2015505359A (ja) 2015-02-19
US20150323537A1 (en) 2015-11-12
US9052318B2 (en) 2015-06-09
EP2771686A4 (en) 2015-03-18
WO2013063147A1 (en) 2013-05-02
US20130130310A1 (en) 2013-05-23
EP2771686A1 (en) 2014-09-03
US20140287430A1 (en) 2014-09-25
CA2853343A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
US20250352189A1 (en) Non-invasive skin collection system
CA2956723C (en) System and method for monitoring health based on collected bodily fluid
Stoy et al. Programmed death‐ligand 1 testing of lung cancer cytology specimens obtained with bronchoscopy
Vairo et al. Towards addressing the body electrolyte environment via sweat analysis: pilocarpine iontophoresis supports assessment of plasma potassium concentration
Olms et al. Clinical comparison of liquid-based and conventional cytology of oral brush biopsies: a randomized controlled trial
Forae et al. Benign breast diseases in Warri Southern Nigeria: A spectrum of histopathological analysis
Woud et al. Direct detection of circulating donor-derived extracellular vesicles in kidney transplant recipients
US9052318B2 (en) Absorbent paper and use thereof for breast cancer detection
Zhao et al. Effects of an Omaha system-based continuing nursing program on nutritional status in patients undergoing peritoneal dialysis: a randomized controlled trial
Lozano-Sanroma et al. Impact of plasma rich in growth factors (PRGF) eye drops on ocular redness and symptomatology in patients with dry eye disease
Nemes-Baran et al. Quantification of microglial contact and engulfment of oligodendrocyte progenitor cells in the rodent brain
CN104040346A (zh) 乳腺癌检测方法
WO2022194033A1 (zh) 一种弥漫大b细胞淋巴瘤的外周血tcr标志物及其检测试剂盒和应用
CN114965753A (zh) 一种lgals3bp蛋白丰度检测试剂在制备妊娠期糖尿病泪液诊断试剂中的应用
Tasaki et al. Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients
CN105929168A (zh) 乳腺癌肿瘤标志物ca153的双阈值检测试纸
JP2015505359A5 (enExample)
Liu et al. Clinical significance of GRHL3 expression in diffuse large B cell lymphoma
Gomes et al. Apical periodontitis and its association with systemic biomarkers: bibliometric analysis of global scientific production and knowledge compilation map
Suman et al. Proteomics in Human Healthcare: A Tool in Disease Diagnosis
da Silva et al. Impact of owners’ perception and socioeconomic status on the treatment and clinical outcome of mammary neoplasms in female dogs
Hofman Advances in theranostic biomarkers for lung cancer from clinical to molecular pathology
van Steenhoven Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?
Salcedo Canine Detection of the Volatile Organic Compounds Related to Cervical Cancer Cells
Kuzmenko et al. Innovative analysis of blood

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140910